Literature DB >> 1475190

A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.

L D Taylor1, C E Carmack, S R Schramm, R Mashayekh, K M Higgins, C C Kuo, C Woodhouse, R M Kay, N Lonberg.   

Abstract

We have generated transgenic mice that express a diverse repertoire of human sequence immunoglobulins. The expression of this repertoire is directed by light and heavy chain minilocus transgenes comprised of human protein coding sequences in an unrearranged, germ-line configuration. In this paper we describe the construction of these miniloci and the composition of the CDR3 repertoire generated by the transgenic mice. The largest transgene discussed is a heavy chain minilocus that includes human mu and gamma 1 coding sequences together with their respective switch regions. It consists of a single 61 kb DNA fragment propagated in a bacterial plasmid vector. Both human heavy chain classes are expressed in animals that carry the transgene. In light chain transgenic animals the unrearranged minilocus sequences recombine to form VJ joints that use all five human J kappa segments, resulting in a diversity of human-like CDR3 regions. Similarly, in heavy chain transgenics the inserted sequences undergo VDJ joining complete with N region addition to generate a human-like VH CDR3 repertoire. All six human JH segments and at least eight of the ten transgene encoded human D segments are expressed. The transgenic animals described in this paper represent a potential source of human sequence antibodies for in vivo therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475190      PMCID: PMC334518          DOI: 10.1093/nar/20.23.6287

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  The V kappa gene repertoire in the human germ line.

Authors:  A Meindl; H G Klobeck; R Ohnheiser; H G Zachau
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

Review 2.  Regulation of the assembly and expression of variable-region genes.

Authors:  G D Yancopoulos; F W Alt
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints.

Authors:  M R Lieber; J E Hesse; K Mizuuchi; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Class switch from mu to delta is mediated by homologous recombination between sigma mu and sigma mu sequences in human immunoglobulin gene loci.

Authors:  H Yasui; Y Akahori; M Hirano; K Yamada; Y Kurosawa
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

5.  Synthetic sites for transcription termination and a functional comparison with tryptophan operon termination sites in vitro.

Authors:  G E Christie; P J Farnham; T Platt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

7.  Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences.

Authors:  A J Feeney
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

8.  Amino acids at the site of V kappa-J kappa recombination not encoded by germline sequences.

Authors:  M Heller; J D Owens; J F Mushinski; S Rudikoff
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

9.  A conserved human germline V kappa gene directly encodes rheumatoid factor light chains.

Authors:  V Radoux; P P Chen; J A Sorge; D A Carson
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes.

Authors:  M Yamada; R Wasserman; B A Reichard; S Shane; A J Caton; G Rovera
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 2.  Research and development of next generation of antibody-based therapeutics.

Authors:  Jing Li; Zhenping Zhu
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

Review 3.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Use of D gene segments with irregular spacers in terminal deoxynucleotidyltransferase (TdT)+/+ and TdT-/- mice carrying a human Ig heavy chain transgenic minilocus.

Authors:  N Tuaillon; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.

Authors:  E-Chiang Lee; Qi Liang; Hanif Ali; Luke Bayliss; Alastair Beasley; Tara Bloomfield-Gerdes; Laura Bonoli; Richard Brown; Jamie Campbell; Adam Carpenter; Sara Chalk; Alison Davis; Nick England; Alla Fane-Dremucheva; Bettina Franz; Volker Germaschewski; Helen Holmes; Steve Holmes; Ian Kirby; Miha Kosmac; Anais Legent; Hui Lui; Anais Manin; Siobhan O'Leary; Jemima Paterson; Rocco Sciarrillo; Anneliese Speak; Dominik Spensberger; Laura Tuffery; Nikole Waddell; Wei Wang; Sophie Wells; Vivian Wong; Andrew Wood; Michael J Owen; Glenn A Friedrich; Allan Bradley
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

6.  Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.

Authors:  Alex Klarenbeek; Khalil El Mazouari; Aline Desmyter; Christophe Blanchetot; Anna Hultberg; Natalie de Jonge; Rob C Roovers; Christian Cambillau; Sylvia Spinelli; Jurgen Del-Favero; Theo Verrips; Hans J de Haard; Ikbel Achour
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Antibodies generated from human immunoglobulin miniloci in transgenic mice.

Authors:  S D Wagner; G T Williams; T Larson; M S Neuberger; D Kitamura; K Rajewsky; J Xian; M Brüggemann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

9.  Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.

Authors:  N Tuaillon; L D Taylor; N Lonberg; P W Tucker; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Yeast artificial chromosome contigs reveal that distal variable-region genes reside at least 3 megabases from the joining regions in the murine immunoglobulin kappa locus.

Authors:  J B George; S Li; W T Garrard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.